To healthy 32 subjects, following treatments are administered dosing in each period and wash-out period is a minimum of 7 days.~Reference drug: D745, D759 / Test drug: CKD-371~Pharmacokinetic blood samples are collected up to 48hrs. The pharmacokinetic characteristics and safety are assessed.
This study is an open-label, randomized, single dose, crossover study to evaluate the pharmacokinetics, safety and tolerability of CKD-388 in healthy subjects